YAINER RODRIGUEZ DELGADO

Allopathic & Osteopathic Physicians|Family Medicine SAN ANTONIO, TX NPI 1548898950

General Payments — all program years on this page

$741.46

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 37
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $438.90 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $438.9022

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $302.5615
2024 $438.9022

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096804246 Novo Nordisk Inc $15.16 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096902191 Novo Nordisk Inc $23.64 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097339964 Novo Nordisk Inc $20.62 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105965492 ABBVIE INC. $19.73 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105965494 ABBVIE INC. $28.22 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105965496 ABBVIE INC. $31.15 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117668889 Amgen Inc. $14.99 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117668891 Amgen Inc. $23.08 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117668893 Amgen Inc. $14.94 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126637002 Acella Pharmaceuticals, LLC $22.86 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126637004 Acella Pharmaceuticals, LLC $20.50 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126637006 Acella Pharmaceuticals, LLC $20.53 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126637008 Acella Pharmaceuticals, LLC $19.80 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131122575 PFIZER INC. $15.25 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131398190 PFIZER INC. $16.45 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131398510 PFIZER INC. $15.35 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135474958 Lilly USA, LLC $17.85 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135483481 Lilly USA, LLC $29.90 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135486043 Lilly USA, LLC $21.01 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135486045 Lilly USA, LLC $18.33 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146481995 Antares Pharma, Inc. $15.00 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153563142 Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.54 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.